HEADER OXIDOREDUCTASE 20-OCT-14 4D38 TITLE STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME TITLE 2 DOMAIN IN COMPLEX WITH (1R,2R)-2-(3-FLUOROBENZYL)-N-{2-[2- TITLE 3 (1H-IMIDAZOL-1-YL)PYRIMIDIN-4-YL]ETHYL}CYCLOPROPANAMINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: NITRIC OXIDE SYNTHASE, ENDOTHELIAL; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: HEME DOMAIN, UNP RESIDUES 40-482; COMPND 5 SYNONYM: CONSTITUTIVE NOS, CNOS, EC-NOS, ENDOTHELIAL NOS, ENOS, NOS COMPND 6 TYPE III, NOSIII, ENDOTHELIAL NITRIC OXIDE SYNTHASE; COMPND 7 EC: 1.14.13.39; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 3 ORGANISM_COMMON: CATTLE; SOURCE 4 ORGANISM_TAXID: 9913; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PCWORI KEYWDS OXIDOREDUCTASE, NITRIC OXIDE SYNTHASE, INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR H.LI,T.L.POULOS REVDAT 2 04-MAR-15 4D38 1 JRNL REVDAT 1 24-DEC-14 4D38 0 JRNL AUTH P.MUKHERJEE,H.LI,I.SEVRIOUKOVA,G.CHREIFI,P.MARTASEK, JRNL AUTH 2 L.J.ROMAN,T.L.POULOS,R.B.SILVERMAN JRNL TITL NOVEL 2,4-DISUBSTITUTED PYRIMIDINES AS POTENT, SELECTIVE, JRNL TITL 2 AND CELL-PERMEABLE INHIBITORS OF NEURONAL NITRIC OXIDE JRNL TITL 3 SYNTHASE. JRNL REF J.MED.CHEM. V. 58 1067 2015 JRNL REFN ISSN 0022-2623 JRNL PMID 25489882 JRNL DOI 10.1021/JM501719E REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VICENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.300 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 78.170 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.34 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.38 REMARK 3 NUMBER OF REFLECTIONS : 43331 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.1768 REMARK 3 R VALUE (WORKING SET) : 0.1740 REMARK 3 FREE R VALUE : 0.2300 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.0 REMARK 3 FREE R VALUE TEST SET COUNT : 2178 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 78.2151 - 5.7950 0.98 2708 158 0.1525 0.1846 REMARK 3 2 5.7950 - 4.5998 0.99 2650 118 0.1296 0.1984 REMARK 3 3 4.5998 - 4.0184 0.99 2592 146 0.1212 0.1662 REMARK 3 4 4.0184 - 3.6510 0.99 2571 129 0.1399 0.1910 REMARK 3 5 3.6510 - 3.3893 0.99 2586 133 0.1530 0.2130 REMARK 3 6 3.3893 - 3.1895 0.99 2563 132 0.1835 0.2548 REMARK 3 7 3.1895 - 3.0297 1.00 2548 136 0.1854 0.2703 REMARK 3 8 3.0297 - 2.8979 1.00 2573 143 0.1909 0.2443 REMARK 3 9 2.8979 - 2.7863 1.00 2585 111 0.2108 0.2640 REMARK 3 10 2.7863 - 2.6901 1.00 2565 127 0.2262 0.3132 REMARK 3 11 2.6901 - 2.6060 1.00 2566 129 0.2413 0.2923 REMARK 3 12 2.6060 - 2.5315 1.00 2519 147 0.2825 0.3591 REMARK 3 13 2.5315 - 2.4649 1.00 2534 149 0.2902 0.3801 REMARK 3 14 2.4649 - 2.4047 1.00 2536 140 0.3097 0.3735 REMARK 3 15 2.4047 - 2.3501 1.00 2551 140 0.3249 0.3978 REMARK 3 16 2.3501 - 2.3000 0.99 2506 140 0.3512 0.3681 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.39 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.65 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 48.56 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 6819 REMARK 3 ANGLE : 1.153 9311 REMARK 3 CHIRALITY : 0.073 972 REMARK 3 PLANARITY : 0.005 1197 REMARK 3 DIHEDRAL : 16.007 2453 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: (CHAIN A AND RESID 67:482) REMARK 3 ORIGIN FOR THE GROUP (A): 11.0985 10.3175 31.7522 REMARK 3 T TENSOR REMARK 3 T11: 0.3468 T22: 0.2741 REMARK 3 T33: 0.3054 T12: -0.0616 REMARK 3 T13: 0.0235 T23: -0.0125 REMARK 3 L TENSOR REMARK 3 L11: 1.0215 L22: 1.3105 REMARK 3 L33: 1.6820 L12: -0.5073 REMARK 3 L13: -0.6122 L23: 0.4513 REMARK 3 S TENSOR REMARK 3 S11: -0.0058 S12: -0.0016 S13: 0.0233 REMARK 3 S21: -0.2195 S22: 0.0881 S23: -0.1632 REMARK 3 S31: -0.0936 S32: 0.0940 S33: -0.0706 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: (CHAIN B AND RESID 69:482) REMARK 3 ORIGIN FOR THE GROUP (A): 2.6572 5.7870 67.6065 REMARK 3 T TENSOR REMARK 3 T11: 0.3091 T22: 0.3377 REMARK 3 T33: 0.3199 T12: -0.0337 REMARK 3 T13: 0.0074 T23: 0.0023 REMARK 3 L TENSOR REMARK 3 L11: 0.7130 L22: 1.5031 REMARK 3 L33: 2.7868 L12: -0.4395 REMARK 3 L13: 0.5223 L23: -0.8768 REMARK 3 S TENSOR REMARK 3 S11: 0.0571 S12: -0.1034 S13: -0.0382 REMARK 3 S21: 0.0702 S22: 0.0410 S23: 0.0074 REMARK 3 S31: 0.0145 S32: -0.0304 S33: -0.0752 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4D38 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 21-OCT-14. REMARK 100 THE PDBE ID CODE IS EBI-62020. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-SEP-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.2.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD (QUANTUM 315R) REMARK 200 DETECTOR MANUFACTURER : ADSC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 43431 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.30 REMARK 200 RESOLUTION RANGE LOW (A) : 50.00 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.0 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 4.9 REMARK 200 R MERGE (I) : 0.13 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.70 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.42 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.9 REMARK 200 R MERGE FOR SHELL (I) : 1.50 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 0.70 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: NONE REMARK 200 REMARK 200 REMARK: RMERGE 2.333 RPIM 1.763 CC ONE HALF 0.251 REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.7 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.5 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20-22% PEG3350, 0.1 M REMARK 280 CACODYLATE, 150-200 MM MG ACETATE, 5 MM TCEP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 28.93500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 78.17000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 53.01000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 78.17000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 28.93500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 53.01000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 10850 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 32130 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -122.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG A 40 REMARK 465 ALA A 41 REMARK 465 PRO A 42 REMARK 465 ALA A 43 REMARK 465 PRO A 44 REMARK 465 ALA A 45 REMARK 465 THR A 46 REMARK 465 PRO A 47 REMARK 465 HIS A 48 REMARK 465 ALA A 49 REMARK 465 PRO A 50 REMARK 465 ASP A 51 REMARK 465 HIS A 52 REMARK 465 SER A 53 REMARK 465 PRO A 54 REMARK 465 ALA A 55 REMARK 465 PRO A 56 REMARK 465 ASN A 57 REMARK 465 SER A 58 REMARK 465 PRO A 59 REMARK 465 THR A 60 REMARK 465 LEU A 61 REMARK 465 THR A 62 REMARK 465 ARG A 63 REMARK 465 PRO A 64 REMARK 465 PRO A 65 REMARK 465 GLU A 66 REMARK 465 ARG A 109 REMARK 465 LYS A 110 REMARK 465 LEU A 111 REMARK 465 GLN A 112 REMARK 465 THR A 113 REMARK 465 ARG A 114 REMARK 465 PRO A 115 REMARK 465 SER A 116 REMARK 465 PRO A 117 REMARK 465 GLY A 118 REMARK 465 PRO A 119 REMARK 465 PRO A 120 REMARK 465 ARG B 40 REMARK 465 ALA B 41 REMARK 465 PRO B 42 REMARK 465 ALA B 43 REMARK 465 PRO B 44 REMARK 465 ALA B 45 REMARK 465 THR B 46 REMARK 465 PRO B 47 REMARK 465 HIS B 48 REMARK 465 ALA B 49 REMARK 465 PRO B 50 REMARK 465 ASP B 51 REMARK 465 HIS B 52 REMARK 465 SER B 53 REMARK 465 PRO B 54 REMARK 465 ALA B 55 REMARK 465 PRO B 56 REMARK 465 ASN B 57 REMARK 465 SER B 58 REMARK 465 PRO B 59 REMARK 465 THR B 60 REMARK 465 LEU B 61 REMARK 465 THR B 62 REMARK 465 ARG B 63 REMARK 465 PRO B 64 REMARK 465 PRO B 65 REMARK 465 GLU B 66 REMARK 465 GLY B 67 REMARK 465 PRO B 68 REMARK 465 LYS B 110 REMARK 465 LEU B 111 REMARK 465 GLN B 112 REMARK 465 THR B 113 REMARK 465 ARG B 114 REMARK 465 PRO B 115 REMARK 465 SER B 116 REMARK 465 PRO B 117 REMARK 465 GLY B 118 REMARK 465 PRO B 119 REMARK 465 PRO B 120 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 69 33.29 -83.50 REMARK 500 SER A 145 -175.53 -66.05 REMARK 500 ASN A 285 42.24 -154.95 REMARK 500 PHE A 288 43.39 -144.17 REMARK 500 ALA A 353 64.45 -156.44 REMARK 500 ARG A 374 -130.33 -114.96 REMARK 500 LYS B 194 78.94 -102.91 REMARK 500 ASP B 202 48.38 -95.19 REMARK 500 ASP B 260 38.38 -90.25 REMARK 500 SER B 262 173.15 -59.73 REMARK 500 ASN B 285 31.07 -149.34 REMARK 500 ALA B 353 63.61 -152.44 REMARK 500 THR B 366 -63.53 -97.50 REMARK 500 ARG B 374 -133.04 -118.70 REMARK 500 PRO B 473 150.74 -49.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 500 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HEM A 500 NB REMARK 620 2 HEM A 500 NC 92.6 REMARK 620 3 CYS A 186 SG 90.0 91.7 REMARK 620 4 HEM A 500 ND 174.2 86.8 95.8 REMARK 620 5 L5Z A 800 N01 80.2 86.0 169.8 94.1 REMARK 620 6 HEM A 500 NA 90.0 175.7 91.7 90.3 91.0 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM B 500 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HEM B 500 ND REMARK 620 2 HEM B 500 NB 178.7 REMARK 620 3 HEM B 500 NA 92.0 87.1 REMARK 620 4 L5Z B 800 N01 91.2 89.7 90.2 REMARK 620 5 HEM B 500 NC 91.1 89.8 175.0 93.7 REMARK 620 6 CYS B 186 SG 92.6 86.5 91.5 175.8 84.4 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A1483 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS B 101 SG REMARK 620 2 CYS B 96 SG 110.1 REMARK 620 3 CYS A 101 SG 109.3 102.4 REMARK 620 4 CYS A 96 SG 107.8 117.3 109.6 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM A 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE H4B A 600 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE L5Z A 800 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 860 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 880 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM B 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE H4B B 600 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE L5Z B 800 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT B 860 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 880 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A1483 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4D2Y RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME REMARK 900 DOMAIN IN COMPLEX WITH N-2-(2-(1H-IMIDAZOL-1-YL) REMARK 900 PYRIMIDIN-4-YL)ETHYL-(S,R)-2-(3-FLUOROBENZYL) REMARK 900 CYCLOPROPAN-1-AMINE REMARK 900 RELATED ID: 4D2Z RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME REMARK 900 DOMAIN IN COMPLEX WITH N-2-(2-(1H-IMIDAZOL-1-YL) REMARK 900 PYRIMIDIN-4-YL)ETHYL-(R,S)-2-(3-FLUOROBENZYL) REMARK 900 CYCLOPROPAN-1-AMINE REMARK 900 RELATED ID: 4D30 RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME REMARK 900 DOMAIN IN COMPLEX WITH N-2-(2-(1H-IMIDAZOL-1-YL) REMARK 900 PYRIMIDIN-4-YL)ETHYL-3-(PYRIDIN-3-YL)PROPAN-1- REMARK 900 AMINE REMARK 900 RELATED ID: 4D31 RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME REMARK 900 DOMAIN IN COMPLEX WITH 2-(2-(1H-IMIDAZOL-1-YL) REMARK 900 PYRIMIDIN-4-YL)-N-(3-CYANOBENZYL)ETHAN-1-AMINE REMARK 900 RELATED ID: 4D32 RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME REMARK 900 DOMAIN IN COMPLEX WITH 3-(3-FLUOROPHENYL)-N-2-(2-( REMARK 900 5-METHYL-1H-IMIDAZOL-1-YL)PYRIMIDIN-4-YL)ETHYLPROPAN REMARK 900 -1-AMINE REMARK 900 RELATED ID: 4D33 RELATED DB: PDB REMARK 900 STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE REMARK 900 HEME DOMAIN IN COMPLEX WITH (N1-(2-(1H-IMIDAZOL-1- REMARK 900 YL)PYRIMIDIN-4-YL)-N2-(3-FLUOROPHENETHYL)ETHANE-1,2 REMARK 900 -DIAMINE REMARK 900 RELATED ID: 4D34 RELATED DB: PDB REMARK 900 STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE REMARK 900 HEME DOMAIN IN COMPLEX WITH 2-(2-(1H-IMIDAZOL-1-YL REMARK 900 )PYRIMIDIN-4-YL)-N-(3-FLUOROPHENETHYL)ETHAN-1-AMINE REMARK 900 RELATED ID: 4D35 RELATED DB: PDB REMARK 900 STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE REMARK 900 HEME DOMAIN IN COMPLEX WITH N-2-(2-(1H-IMIDAZOL-1 REMARK 900 -YL)PYRIMIDIN-4-YL)ETHYL-3-(3-FLUOROPHENYL)PROPAN-1 REMARK 900 -AMINE REMARK 900 RELATED ID: 4D36 RELATED DB: PDB REMARK 900 STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE REMARK 900 HEME DOMAIN IN COMPLEX WITH N-2-(2-(1H-IMIDAZOL-1 REMARK 900 -YL)PYRIMIDIN-4-YL)ETHYL-3-(3-CHLOROPHENYL)PROPAN-1 REMARK 900 -AMINE REMARK 900 RELATED ID: 4D37 RELATED DB: PDB REMARK 900 STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE REMARK 900 HEME DOMAIN IN COMPLEX WITHN-{[(1R,2R)-2-(3- REMARK 900 FLUOROPHENYL)CYCLOPROPYL]METHYL}-2-[2-(1H-IMIDAZOL-1- REMARK 900 YL)PYRIMIDIN-4-YL]ETHANAMINE REMARK 900 RELATED ID: 4D39 RELATED DB: PDB REMARK 900 STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE REMARK 900 HEME DOMAIN IN COMPLEX WITH2-(2-(1H-IMIDAZOL-1-YL) REMARK 900 PYRIMIDIN-4-YL)-N-(3-CYANOBENZYL)ETHAN-1-AMINE REMARK 900 RELATED ID: 4D3A RELATED DB: PDB REMARK 900 STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE REMARK 900 HEME DOMAIN IN COMPLEX WITH 3-(3-FLUOROPHENYL)-N-2 REMARK 900 -(2-(5-METHYL-1H-IMIDAZOL-1-YL)PYRIMIDIN-4-YL) REMARK 900 ETHYLPROPAN-1-AMINE REMARK 900 RELATED ID: 4D3B RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME REMARK 900 DOMAIN IN COMPLEX WITH N1-(2-(1H-IMIDAZOL-1-YL) REMARK 900 PYRIMIDIN-4-YL)-N2-(3-FLUOROPHENETHYL)ETHANE-1,2- REMARK 900 DIAMINE REMARK 900 RELATED ID: 4V3U RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN NNOS R354A G357D MUTANT HEME DOMAIN REMARK 900 IN COMPLEX WITH N-2-(2-(1H-IMIDAZOL-1-YL) REMARK 900 PYRIMIDIN-4-YL)ETHYL-3-(PYRIDIN-3-YL)PROPAN-1- REMARK 900 AMINE REMARK 900 RELATED ID: 4V3V RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME REMARK 900 DOMAIN IN COMPLEX WITH N-(2-(1H-IMIDAZOL-1-YL)-4- REMARK 900 PYRIMIDYLMETHYL)-3-(3-FLUOROPHENYL)PROPAN-1-AMINE REMARK 900 RELATED ID: 4V3W RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME REMARK 900 DOMAIN IN COMPLEX WITH 2-(2-(1H-IMIDAZOL-1-YL) REMARK 900 PYRIMIDIN-4-YL)-N-(3-FLUOROPHENETHYL)ETHAN-1-AMINE REMARK 900 RELATED ID: 4V3X RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME REMARK 900 DOMAIN IN COMPLEX WITH N-2-(2-(1H-IMIDAZOL-1-YL) REMARK 900 PYRIMIDIN-4-YL)ETHYL-3-(3-FLUOROPHENYL)PROPAN-1- REMARK 900 AMINE REMARK 900 RELATED ID: 4V3Y RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME REMARK 900 DOMAIN IN COMPLEX WITH N-2-(2-(1H-IMIDAZOL-1-YL) REMARK 900 PYRIMIDIN-4-YL)ETHYL-3-(3-CHLOROPHENYL)PROPAN-1- REMARK 900 AMINE REMARK 900 RELATED ID: 4V3Z RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME REMARK 900 DOMAIN IN COMPLEX WITH 2-(2-(1H-IMIDAZOL-1-YL) REMARK 900 PYRIMIDIN-4-YL)-N-(2-(3-FLUOROPHENYL)CYCLOPROPYLMETHYL) REMARK 900 ETHAN-1-AMINE REMARK 999 REMARK 999 SEQUENCE REMARK 999 RESIDUE 100 IS FOUND AS AN ARG IN STRUCTURE BUT IS A CYS REMARK 999 IN DATABASE DBREF 4D38 A 40 482 UNP P29473 NOS3_BOVIN 40 482 DBREF 4D38 B 40 482 UNP P29473 NOS3_BOVIN 40 482 SEQADV 4D38 ARG A 100 UNP P29473 CYS 100 SEE REMARK 999 SEQADV 4D38 ARG B 100 UNP P29473 CYS 100 SEE REMARK 999 SEQRES 1 A 443 ARG ALA PRO ALA PRO ALA THR PRO HIS ALA PRO ASP HIS SEQRES 2 A 443 SER PRO ALA PRO ASN SER PRO THR LEU THR ARG PRO PRO SEQRES 3 A 443 GLU GLY PRO LYS PHE PRO ARG VAL LYS ASN TRP GLU LEU SEQRES 4 A 443 GLY SER ILE THR TYR ASP THR LEU CYS ALA GLN SER GLN SEQRES 5 A 443 GLN ASP GLY PRO CYS THR PRO ARG ARG CYS LEU GLY SER SEQRES 6 A 443 LEU VAL LEU PRO ARG LYS LEU GLN THR ARG PRO SER PRO SEQRES 7 A 443 GLY PRO PRO PRO ALA GLU GLN LEU LEU SER GLN ALA ARG SEQRES 8 A 443 ASP PHE ILE ASN GLN TYR TYR SER SER ILE LYS ARG SER SEQRES 9 A 443 GLY SER GLN ALA HIS GLU GLU ARG LEU GLN GLU VAL GLU SEQRES 10 A 443 ALA GLU VAL ALA SER THR GLY THR TYR HIS LEU ARG GLU SEQRES 11 A 443 SER GLU LEU VAL PHE GLY ALA LYS GLN ALA TRP ARG ASN SEQRES 12 A 443 ALA PRO ARG CYS VAL GLY ARG ILE GLN TRP GLY LYS LEU SEQRES 13 A 443 GLN VAL PHE ASP ALA ARG ASP CYS SER SER ALA GLN GLU SEQRES 14 A 443 MET PHE THR TYR ILE CYS ASN HIS ILE LYS TYR ALA THR SEQRES 15 A 443 ASN ARG GLY ASN LEU ARG SER ALA ILE THR VAL PHE PRO SEQRES 16 A 443 GLN ARG ALA PRO GLY ARG GLY ASP PHE ARG ILE TRP ASN SEQRES 17 A 443 SER GLN LEU VAL ARG TYR ALA GLY TYR ARG GLN GLN ASP SEQRES 18 A 443 GLY SER VAL ARG GLY ASP PRO ALA ASN VAL GLU ILE THR SEQRES 19 A 443 GLU LEU CYS ILE GLN HIS GLY TRP THR PRO GLY ASN GLY SEQRES 20 A 443 ARG PHE ASP VAL LEU PRO LEU LEU LEU GLN ALA PRO ASP SEQRES 21 A 443 GLU ALA PRO GLU LEU PHE VAL LEU PRO PRO GLU LEU VAL SEQRES 22 A 443 LEU GLU VAL PRO LEU GLU HIS PRO THR LEU GLU TRP PHE SEQRES 23 A 443 ALA ALA LEU GLY LEU ARG TRP TYR ALA LEU PRO ALA VAL SEQRES 24 A 443 SER ASN MET LEU LEU GLU ILE GLY GLY LEU GLU PHE SER SEQRES 25 A 443 ALA ALA PRO PHE SER GLY TRP TYR MET SER THR GLU ILE SEQRES 26 A 443 GLY THR ARG ASN LEU CYS ASP PRO HIS ARG TYR ASN ILE SEQRES 27 A 443 LEU GLU ASP VAL ALA VAL CAS MET ASP LEU ASP THR ARG SEQRES 28 A 443 THR THR SER SER LEU TRP LYS ASP LYS ALA ALA VAL GLU SEQRES 29 A 443 ILE ASN LEU ALA VAL LEU HIS SER PHE GLN LEU ALA LYS SEQRES 30 A 443 VAL THR ILE VAL ASP HIS HIS ALA ALA THR VAL SER PHE SEQRES 31 A 443 MET LYS HIS LEU ASP ASN GLU GLN LYS ALA ARG GLY GLY SEQRES 32 A 443 CYS PRO ALA ASP TRP ALA TRP ILE VAL PRO PRO ILE SER SEQRES 33 A 443 GLY SER LEU THR PRO VAL PHE HIS GLN GLU MET VAL ASN SEQRES 34 A 443 TYR ILE LEU SER PRO ALA PHE ARG TYR GLN PRO ASP PRO SEQRES 35 A 443 TRP SEQRES 1 B 443 ARG ALA PRO ALA PRO ALA THR PRO HIS ALA PRO ASP HIS SEQRES 2 B 443 SER PRO ALA PRO ASN SER PRO THR LEU THR ARG PRO PRO SEQRES 3 B 443 GLU GLY PRO LYS PHE PRO ARG VAL LYS ASN TRP GLU LEU SEQRES 4 B 443 GLY SER ILE THR TYR ASP THR LEU CYS ALA GLN SER GLN SEQRES 5 B 443 GLN ASP GLY PRO CYS THR PRO ARG ARG CYS LEU GLY SER SEQRES 6 B 443 LEU VAL LEU PRO ARG LYS LEU GLN THR ARG PRO SER PRO SEQRES 7 B 443 GLY PRO PRO PRO ALA GLU GLN LEU LEU SER GLN ALA ARG SEQRES 8 B 443 ASP PHE ILE ASN GLN TYR TYR SER SER ILE LYS ARG SER SEQRES 9 B 443 GLY SER GLN ALA HIS GLU GLU ARG LEU GLN GLU VAL GLU SEQRES 10 B 443 ALA GLU VAL ALA SER THR GLY THR TYR HIS LEU ARG GLU SEQRES 11 B 443 SER GLU LEU VAL PHE GLY ALA LYS GLN ALA TRP ARG ASN SEQRES 12 B 443 ALA PRO ARG CYS VAL GLY ARG ILE GLN TRP GLY LYS LEU SEQRES 13 B 443 GLN VAL PHE ASP ALA ARG ASP CYS SER SER ALA GLN GLU SEQRES 14 B 443 MET PHE THR TYR ILE CYS ASN HIS ILE LYS TYR ALA THR SEQRES 15 B 443 ASN ARG GLY ASN LEU ARG SER ALA ILE THR VAL PHE PRO SEQRES 16 B 443 GLN ARG ALA PRO GLY ARG GLY ASP PHE ARG ILE TRP ASN SEQRES 17 B 443 SER GLN LEU VAL ARG TYR ALA GLY TYR ARG GLN GLN ASP SEQRES 18 B 443 GLY SER VAL ARG GLY ASP PRO ALA ASN VAL GLU ILE THR SEQRES 19 B 443 GLU LEU CYS ILE GLN HIS GLY TRP THR PRO GLY ASN GLY SEQRES 20 B 443 ARG PHE ASP VAL LEU PRO LEU LEU LEU GLN ALA PRO ASP SEQRES 21 B 443 GLU ALA PRO GLU LEU PHE VAL LEU PRO PRO GLU LEU VAL SEQRES 22 B 443 LEU GLU VAL PRO LEU GLU HIS PRO THR LEU GLU TRP PHE SEQRES 23 B 443 ALA ALA LEU GLY LEU ARG TRP TYR ALA LEU PRO ALA VAL SEQRES 24 B 443 SER ASN MET LEU LEU GLU ILE GLY GLY LEU GLU PHE SER SEQRES 25 B 443 ALA ALA PRO PHE SER GLY TRP TYR MET SER THR GLU ILE SEQRES 26 B 443 GLY THR ARG ASN LEU CYS ASP PRO HIS ARG TYR ASN ILE SEQRES 27 B 443 LEU GLU ASP VAL ALA VAL CAS MET ASP LEU ASP THR ARG SEQRES 28 B 443 THR THR SER SER LEU TRP LYS ASP LYS ALA ALA VAL GLU SEQRES 29 B 443 ILE ASN LEU ALA VAL LEU HIS SER PHE GLN LEU ALA LYS SEQRES 30 B 443 VAL THR ILE VAL ASP HIS HIS ALA ALA THR VAL SER PHE SEQRES 31 B 443 MET LYS HIS LEU ASP ASN GLU GLN LYS ALA ARG GLY GLY SEQRES 32 B 443 CYS PRO ALA ASP TRP ALA TRP ILE VAL PRO PRO ILE SER SEQRES 33 B 443 GLY SER LEU THR PRO VAL PHE HIS GLN GLU MET VAL ASN SEQRES 34 B 443 TYR ILE LEU SER PRO ALA PHE ARG TYR GLN PRO ASP PRO SEQRES 35 B 443 TRP MODRES 4D38 CAS A 384 CYS S-(DIMETHYLARSENIC)CYSTEINE MODRES 4D38 CAS B 384 CYS S-(DIMETHYLARSENIC)CYSTEINE HET CAS A 384 9 HET HEM A 500 43 HET H4B A 600 17 HET L5Z A 800 25 HET ACT A 860 4 HET GOL A 880 6 HET CAS B 384 9 HET HEM B 500 43 HET H4B B 600 17 HET L5Z B 800 25 HET ACT B 860 4 HET GOL B 880 6 HET ZN A1483 1 HETNAM H4B 5,6,7,8-TETRAHYDROBIOPTERIN HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM L5Z (1R,2R)-2-(3-FLUOROBENZYL)-N-{2-[2-(1H- HETNAM 2 L5Z IMIDAZOL-1-YL)PYRIMIDIN-4-YL]ETHYL} HETNAM 3 L5Z CYCLOPROPANAMINE HETNAM ZN ZINC ION HETNAM GOL GLYCEROL HETNAM ACT ACETATE ION HETNAM CAS S-(DIMETHYLARSENIC)CYSTEINE HETSYN HEM HEME HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 H4B 2(C9 H15 N5 O3) FORMUL 4 HEM 2(C34 H32 FE N4 O4) FORMUL 5 L5Z 2(C19 H20 F N5) FORMUL 6 ZN ZN 2+ FORMUL 7 GOL 2(C3 H8 O3) FORMUL 8 ACT 2(C2 H3 O2 1-) FORMUL 9 CAS 2(C5 H12 AS N O2 S) FORMUL 10 HOH *249(H2 O) HELIX 1 1 THR A 85 SER A 90 5 6 HELIX 2 2 PRO A 121 ILE A 140 1 20 HELIX 3 3 SER A 145 GLY A 163 1 19 HELIX 4 4 ARG A 168 ALA A 183 1 16 HELIX 5 5 GLY A 188 TRP A 192 5 5 HELIX 6 6 SER A 205 ASN A 222 1 18 HELIX 7 7 ARG A 223 ASN A 225 5 3 HELIX 8 8 ASN A 269 HIS A 279 1 11 HELIX 9 9 PRO A 308 VAL A 312 5 5 HELIX 10 10 TRP A 324 GLY A 329 5 6 HELIX 11 11 SER A 361 THR A 366 1 6 HELIX 12 12 THR A 366 ASP A 371 1 6 HELIX 13 13 ILE A 377 ASP A 386 1 10 HELIX 14 14 THR A 391 SER A 394 5 4 HELIX 15 15 LEU A 395 ALA A 415 1 21 HELIX 16 16 ASP A 421 GLY A 441 1 21 HELIX 17 17 ASP A 446 VAL A 451 1 6 HELIX 18 18 SER A 455 THR A 459 5 5 HELIX 19 19 THR A 459 HIS A 463 5 5 HELIX 20 20 THR B 85 SER B 90 5 6 HELIX 21 21 PRO B 121 ILE B 140 1 20 HELIX 22 22 SER B 145 GLY B 163 1 19 HELIX 23 23 ARG B 168 ALA B 183 1 16 HELIX 24 24 GLY B 188 TRP B 192 5 5 HELIX 25 25 SER B 205 ASN B 222 1 18 HELIX 26 26 ARG B 223 ASN B 225 5 3 HELIX 27 27 ASN B 269 HIS B 279 1 11 HELIX 28 28 PRO B 308 VAL B 312 5 5 HELIX 29 29 TRP B 324 GLY B 329 5 6 HELIX 30 30 MET B 360 THR B 366 1 7 HELIX 31 31 THR B 366 ASP B 371 1 6 HELIX 32 32 ILE B 377 MET B 385 1 9 HELIX 33 33 THR B 391 SER B 394 5 4 HELIX 34 34 LEU B 395 ALA B 415 1 21 HELIX 35 35 ASP B 421 GLY B 441 1 21 HELIX 36 36 ASP B 446 VAL B 451 1 6 HELIX 37 37 SER B 455 THR B 459 5 5 HELIX 38 38 THR B 459 HIS B 463 5 5 SHEET 1 AA 2 ARG A 72 LYS A 74 0 SHEET 2 AA 2 ILE A 81 TYR A 83 -1 O THR A 82 N VAL A 73 SHEET 1 AB 4 GLN A 196 ASP A 199 0 SHEET 2 AB 4 ALA A 229 VAL A 232 1 O ILE A 230 N PHE A 198 SHEET 3 AB 4 PHE A 355 SER A 356 -1 O SER A 356 N ALA A 229 SHEET 4 AB 4 ALA A 337 VAL A 338 -1 O VAL A 338 N PHE A 355 SHEET 1 AC 3 ARG A 244 ILE A 245 0 SHEET 2 AC 3 LEU A 293 GLN A 296 -1 O GLN A 296 N ARG A 244 SHEET 3 AC 3 GLU A 303 PHE A 305 -1 O GLU A 303 N LEU A 295 SHEET 1 AD 2 GLY A 255 ARG A 257 0 SHEET 2 AD 2 VAL A 263 GLY A 265 -1 O ARG A 264 N TYR A 256 SHEET 1 AE 2 GLU A 314 PRO A 316 0 SHEET 2 AE 2 ARG A 331 TYR A 333 -1 O TRP A 332 N VAL A 315 SHEET 1 AF 3 LEU A 348 PHE A 350 0 SHEET 2 AF 3 LEU A 342 ILE A 345 -1 O LEU A 343 N PHE A 350 SHEET 3 AF 3 ALA A 474 ARG A 476 -1 O ALA A 474 N GLU A 344 SHEET 1 AG 2 TYR A 359 MET A 360 0 SHEET 2 AG 2 ILE A 419 VAL A 420 1 N VAL A 420 O TYR A 359 SHEET 1 BA 2 ARG B 72 LYS B 74 0 SHEET 2 BA 2 ILE B 81 TYR B 83 -1 O THR B 82 N VAL B 73 SHEET 1 BB 4 GLN B 196 ASP B 199 0 SHEET 2 BB 4 ALA B 229 VAL B 232 1 O ILE B 230 N PHE B 198 SHEET 3 BB 4 PHE B 355 SER B 356 -1 O SER B 356 N ALA B 229 SHEET 4 BB 4 ALA B 337 VAL B 338 -1 O VAL B 338 N PHE B 355 SHEET 1 BC 3 ARG B 244 ILE B 245 0 SHEET 2 BC 3 LEU B 293 GLN B 296 -1 O GLN B 296 N ARG B 244 SHEET 3 BC 3 GLU B 303 PHE B 305 -1 O GLU B 303 N LEU B 295 SHEET 1 BD 2 GLY B 255 ARG B 257 0 SHEET 2 BD 2 VAL B 263 GLY B 265 -1 O ARG B 264 N TYR B 256 SHEET 1 BE 2 GLU B 314 PRO B 316 0 SHEET 2 BE 2 ARG B 331 TYR B 333 -1 O TRP B 332 N VAL B 315 SHEET 1 BF 3 LEU B 348 PHE B 350 0 SHEET 2 BF 3 LEU B 342 ILE B 345 -1 O LEU B 343 N PHE B 350 SHEET 3 BF 3 ALA B 474 ARG B 476 -1 O ALA B 474 N GLU B 344 LINK SG CYS A 186 FE HEM A 500 1555 1555 2.42 LINK C VAL A 383 N CAS A 384 1555 1555 1.33 LINK C CAS A 384 N MET A 385 1555 1555 1.33 LINK FE HEM A 500 N01 L5Z A 800 1555 1555 2.25 LINK ZN ZN A1483 SG CYS B 101 1555 1555 2.37 LINK ZN ZN A1483 SG CYS B 96 1555 1555 2.50 LINK ZN ZN A1483 SG CYS A 101 1555 1555 2.41 LINK ZN ZN A1483 SG CYS A 96 1555 1555 2.37 LINK SG CYS B 186 FE HEM B 500 1555 1555 2.29 LINK C VAL B 383 N CAS B 384 1555 1555 1.32 LINK C CAS B 384 N MET B 385 1555 1555 1.33 LINK FE HEM B 500 N01 L5Z B 800 1555 1555 2.15 CISPEP 1 SER A 472 PRO A 473 0 4.83 CISPEP 2 SER B 472 PRO B 473 0 -5.37 SITE 1 AC1 19 TRP A 180 ALA A 183 ARG A 185 CYS A 186 SITE 2 AC1 19 SER A 228 PHE A 355 SER A 356 TRP A 358 SITE 3 AC1 19 MET A 360 GLU A 363 TRP A 449 PHE A 475 SITE 4 AC1 19 TYR A 477 H4B A 600 L5Z A 800 HOH A2139 SITE 5 AC1 19 HOH A2140 HOH A2141 HOH A2142 SITE 1 AC2 14 SER A 104 VAL A 106 ARG A 367 ALA A 448 SITE 2 AC2 14 TRP A 449 HEM A 500 GOL A 880 HOH A2104 SITE 3 AC2 14 HOH A2127 HOH A2142 TRP B 447 PHE B 462 SITE 4 AC2 14 GLN B 464 GLU B 465 SITE 1 AC3 8 VAL A 106 LEU A 107 GLN A 249 PRO A 336 SITE 2 AC3 8 VAL A 338 TYR A 477 HEM A 500 GOL A 880 SITE 1 AC4 3 GLY A 188 TRP A 358 SER A 428 SITE 1 AC5 5 ARG A 367 HIS A 373 H4B A 600 L5Z A 800 SITE 2 AC5 5 TRP B 76 SITE 1 AC6 17 TRP B 180 ARG B 185 CYS B 186 GLY B 188 SITE 2 AC6 17 SER B 228 PHE B 355 SER B 356 TRP B 358 SITE 3 AC6 17 MET B 360 GLU B 363 TRP B 449 PHE B 475 SITE 4 AC6 17 TYR B 477 H4B B 600 L5Z B 800 HOH B2104 SITE 5 AC6 17 HOH B2105 SITE 1 AC7 12 TRP A 447 PHE A 462 HOH A2133 SER B 104 SITE 2 AC7 12 VAL B 106 ARG B 367 ALA B 448 TRP B 449 SITE 3 AC7 12 HEM B 500 GOL B 880 HOH B2079 HOH B2097 SITE 1 AC8 8 VAL B 106 LEU B 107 GLN B 249 PRO B 336 SITE 2 AC8 8 VAL B 338 HEM B 500 GOL B 880 HOH B2072 SITE 1 AC9 5 GLN B 191 TRP B 358 VAL B 420 SER B 428 SITE 2 AC9 5 HOH B2106 SITE 1 BC1 6 HOH A2133 VAL B 106 ARG B 367 HIS B 373 SITE 2 BC1 6 H4B B 600 L5Z B 800 SITE 1 BC2 4 CYS A 96 CYS A 101 CYS B 96 CYS B 101 CRYST1 57.870 106.020 156.340 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017280 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009432 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006396 0.00000